no code implementations • 6 Mar 2024 • Thomas Pinetz, Erich Kobler, Robert Haase, Julian A. Luetkens, Mathias Meetschen, Johannes Haubold, Cornelius Deuschl, Alexander Radbruch, Katerina Deike, Alexander Effland
Recently, deep learning (DL)-based methods have been proposed for the computational reduction of gadolinium-based contrast agents (GBCAs) to mitigate adverse side effects while preserving diagnostic value.
